Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UI-EWD for upper gastrointestinal bleeding
NCT02978391Completed
- Sponsor
- Next Biomedical
- Start
- May 2016
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
Randomised, single-blind trial in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Next Biomedical. Primary endpoint: Recurrent bleeding rate at 3 days. Started May 2016; status: completed.
02
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT02978391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02978391.